Completed PHASE2 INTERVENTIONAL 4-arm NCT01902017

Investigations of Mechanisms and Treatment in Post-traumatic Joint Contractures (Ketotifen)

Randomized, Double Blind, Placebo Controlled Trial of Ketotifen in Patients With Elbow Fractures or Dislocations

Sponsor: American Society for Surgery of the Hand

Updated 8 times since 2017 Last updated: Mar 25, 2018 Started: Jun 30, 2013 Primary completion: Aug 31, 2017 Completion: Aug 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01902017, this PHASE2 trial focuses on Joint Contractures and remains completed. Sponsored by American Society for Surgery of the Hand, it has been updated 8 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Dec 2018 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Dec 2018 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
May 2017 — Apr 2018 [monthly]

Active Not Recruiting PHASE2

Phase: PHASE3 → PHASE2
Jan 2017 — May 2017 [monthly]

Active Not Recruiting PHASE3

First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American Society for Surgery of the Hand
Canadian Institutes of Health Research (CIHR)
University of Calgary
Workers' Compensation Board, Alberta

Data source: University of Calgary

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Calgary, Canada